Tag: Pharmacology Research Excellence Award

Mridul Guleria | Pharmacology | Best Researcher Award

Published on by World Science Awards

Best Researcher Award

Mridul Guleria — Guru Nanak Dev University

Mridul Guleria
Affiliation Guru Nanak Dev University
Country India
Scopus ID 59174404600
Documents 14
Citations 84
h-index 4
Subject Area Pharmacology
Event World Science Awards
ORCID 0009-0008-5898-8134

Mridul Guleria is a researcher affiliated with Guru Nanak Dev University, India, whose documented scholarly profile is associated with the field of pharmacology. The available bibliometric record identifies 14 documents, 84 citations, and an h-index of 4 in Scopus. [1] These indicators provide a concise quantitative view of the researcher’s indexed scholarly output and citation visibility.

This academic recognition profile presents the researcher’s research background, contributions, publication record, research impact, and suitability for consideration for the Best Researcher Award associated with the World Science Awards. The assessment is framed using the supplied bibliographic information and publicly identifiable researcher records rather than unsupported claims of distinction.

Abstract

Mridul Guleria is affiliated with Guru Nanak Dev University and works within the subject area of pharmacology. The researcher’s indexed profile records 14 documents, 84 citations, and an h-index of 4. [1] The profile is additionally associated with an ORCID identifier, providing a persistent scholarly identity record. [2] On the basis of the supplied academic indicators, the Best Researcher Award profile highlights scholarly productivity, citation-based visibility, subject-area relevance, and participation in research activities within pharmacology.

Keywords

Mridul Guleria; Best Researcher Award; pharmacology; pharmaceutical research; Guru Nanak Dev University; research impact; scholarly publications; citation analysis; Scopus; ORCID; World Science Awards.

Introduction

Pharmacology is a multidisciplinary area concerned with the study of drugs, their biological effects, mechanisms of action, therapeutic applications, and interactions with living systems. Research in this field contributes to the broader development and evaluation of pharmacological knowledge and can intersect with pharmaceutical sciences, biomedical research, toxicology, and related disciplines.

Within an academic recognition framework, researcher evaluation may consider several dimensions, including research productivity, publication activity, citation performance, subject relevance, originality, scholarly contribution, and broader research influence. Bibliometric databases such as Scopus can provide quantitative indicators for assessing indexed research output, while ORCID provides a persistent identifier that helps distinguish researchers and connect scholarly works with their authors. [1] [2]

Research Profile

The supplied research profile identifies Mridul Guleria as being affiliated with Guru Nanak Dev University in India and specializing in pharmacology.

These figures should be interpreted as a snapshot of the indexed research record and may change as databases update publication and citation information. [1]

Research Contributions

Mridul Guleria’s documented research specialization is pharmacology. The available record supports recognition of research activity within this subject area, while the supplied bibliometric indicators provide evidence of an established indexed publication and citation record. [1]

For academic evaluation purposes, the contribution profile can be considered across the following dimensions:

  • Subject-area engagement: Research activity is associated with pharmacology, a field relevant to drug research and biomedical science.
  • Scholarly productivity: Fourteen documents are recorded in the supplied Scopus profile.
  • Citation visibility: The supplied profile records 84 citations, indicating that indexed publications have received measurable scholarly referencing.
  • Research continuity: The presence of multiple indexed documents provides evidence of continuing scholarly publication activity.
  • Researcher identification: The association of Scopus and ORCID identifiers supports clearer attribution of scholarly work to the researcher. [1] [2]

Publications

The supplied Scopus record indicates 14 indexed documents associated with Mridul Guleria. [1] The available input does not provide a complete publication bibliography, individual article titles, journal names, publication dates, citation distributions, or DOI identifiers. Accordingly, no specific publication titles or DOI values are attributed here without bibliographic verification.

For a complete publication assessment, the Scopus author record and the researcher’s ORCID profile can be consulted to identify publications, author associations, and persistent scholarly records. [1] [2]

Research Impact

The supplied Scopus indicators show 84 citations across 14 documents and an h-index of 4. [1] These measures provide quantitative evidence of citation activity and scholarly visibility within the indexed research literature.

Citation counts and h-index values are useful indicators but should not be interpreted independently of publication context, career stage, discipline, authorship patterns, journal characteristics, or the nature of individual contributions. A balanced assessment of research impact therefore benefits from combining bibliometric information with qualitative evaluation of research originality, methodological quality, relevance, collaboration, and contribution to the field.

The presence of an ORCID identifier further supports persistent researcher identification and can facilitate the reliable association of scholarly outputs with the appropriate researcher. [2]

Award Suitability

The Best Researcher Award profile for Mridul Guleria is supported by the supplied evidence of academic affiliation, subject-area specialization, indexed publication activity, and citation performance. The World Science Awards provides the event context for this recognition. [3]

Based on the available information, relevant evaluation dimensions include:

  • Academic relevance: The researcher’s specialization in pharmacology aligns with a recognized scientific and biomedical research domain.
  • Publication record: Fourteen Scopus-indexed documents demonstrate measurable scholarly productivity. [1]
  • Citation performance: Eighty-four citations provide an observable indicator of scholarly attention to the indexed research output. [1]
  • h-index: An h-index of 4 provides an additional quantitative measure of citation distribution across the researcher’s indexed publications. [1]
  • Researcher identity: The availability of both Scopus and ORCID identifiers supports transparent scholarly attribution. [1] [2]

Taken together, these documented indicators provide a reasonable academic basis for consideration under a Best Researcher Award framework. Final award decisions, however, should be based on the official evaluation methodology, verified publication records, research quality, originality, and other criteria established by the awarding organization. [3]

Conclusion

Mridul Guleria is an India-based researcher affiliated with Guru Nanak Dev University whose documented research area is pharmacology. The supplied scholarly profile records 14 documents, 84 citations, and an h-index of 4 in Scopus, alongside an ORCID identifier that provides a persistent researcher identity. [1] [2]

The available evidence demonstrates measurable research productivity and citation visibility and provides a documented foundation for consideration for the Best Researcher Award at the World Science Awards. [3] Any final recognition should be determined through independent verification and the formal assessment criteria of the awarding body.

References

  1. Elsevier. (n.d.). Scopus author details: Mridul Guleria, Author ID 59174404600. Scopus.
    https://www.scopus.com/pages/authors/59174404600
  2. ORCID. (n.d.). ORCID record: Mridul Guleria, ORCID iD 0009-0008-5898-8134. ORCID.
    https://orcid.org/0009-0008-5898-8134
  3. World Science Awards. (n.d.). World Science Awards.
    https://worldscienceawards.com/

Mohammad Seyedabadi | Pharmacology | Best Researcher Award

Published on by World Science Awards

Best Researcher Award

Mohammad Seyedabadi, Mazandaran University of Medical Sciences
Mohammad Seyedabadi
Affiliation Mazandaran University of Medical Sciences
Country Iran
Scopus ID 24460920400
Documents 86
Citations 2,110
h-index 25
Subject Area Pharmacology
Event World Science Awards
ORCID 0000-0003-0044-8270

Mohammad Seyedabadi is a researcher affiliated with Mazandaran University of Medical Sciences in Iran, with a documented research specialization in pharmacology. The academic recognition presented in this article is the Best Researcher Award associated with the World Science Awards. The supplied research profile records 86 documents, 2,110 citations, and an h-index of 25. These bibliometric indicators provide a quantitative overview of the documented research record and are presented as profile information rather than as independent measures of scientific quality. Pharmacology encompasses the study of drugs, their mechanisms of action, therapeutic effects, adverse effects, and interactions with biological systems. [1][2]

Abstract

This article presents an academic recognition profile for Mohammad SEYEDABADI of Mazandaran University of Medical Sciences, Iran, in connection with the Best Researcher Award under the World Science Awards. The documented research subject is pharmacology, a biomedical discipline concerned with the properties, mechanisms, therapeutic applications, and safety of drugs and other bioactive substances. [1][2] The supplied bibliometric record identifies 86 documents, 2,110 citations, and an h-index of 25. These indicators suggest a substantial indexed research record within the supplied profile, while their interpretation should account for publication history, disciplinary citation practices, collaboration patterns, and the characteristics of individual publications. The award suitability discussion therefore considers the documented research specialization, publication volume, citation activity, and overall bibliometric profile without treating these measures as substitutes for qualitative assessment.

Keywords

  • Pharmacology
  • Drug discovery
  • Pharmacological research
  • Therapeutics
  • Pharmacodynamics
  • Pharmacokinetics
  • Biomedical science
  • Research impact

Introduction

Pharmacology is a central biomedical discipline that examines how chemical substances interact with living systems. It includes the study of drug mechanisms, pharmacodynamics, pharmacokinetics, therapeutic efficacy, adverse effects, and interactions. [1][2] Pharmacological research provides a scientific basis for understanding the actions of medicines and for supporting the development and evaluation of therapeutic interventions.

Modern pharmacology is closely connected with molecular biology, physiology, biochemistry, toxicology, medicinal chemistry, and clinical medicine. Research may range from investigations of molecular targets and signaling pathways to experimental evaluation of candidate compounds and clinical studies of therapeutic responses. The integration of these disciplines has contributed to the development of more selective treatments and improved understanding of drug response variability. [2][3]

Within this scientific context, Mohammad SEYEDABADI is identified in the supplied profile as a pharmacology researcher affiliated with Mazandaran University of Medical Sciences. The reported record of 86 documents, 2,110 citations, and an h-index of 25 provides a quantitative description of the indexed research profile. Further conclusions regarding specific scientific discoveries or therapeutic applications require examination of the underlying publications and verified research outputs.

Research Profile

Mohammad SEYEDABADI is affiliated with Mazandaran University of Medical Sciences in Iran. The supplied subject classification is pharmacology, placing the profile within the broader biomedical and pharmaceutical sciences. The reported combination of publication output and citation activity provides a bibliometric overview of the researcher’s indexed scholarly record. An h-index of 25 indicates that, within the supplied record, at least 25 publications have received at least 25 citations each, subject to the accuracy and coverage of the underlying database record. Bibliometric indicators should nevertheless be interpreted in their disciplinary and temporal context.

Research Contributions

The documented specialization of Mohammad SEYEDABADI is pharmacology. As a broad research field, pharmacology contributes to the scientific understanding of how therapeutic agents interact with biological targets and how those interactions influence physiological and pathological processes. [1][2] Pharmacological investigations may address molecular mechanisms, drug efficacy, safety, metabolism, therapeutic response, and interactions between medicines.

The supplied profile does not identify specific publication titles, experimental models, molecular targets, compounds, therapeutic areas, or clinical outcomes. Therefore, specific technical contributions are not attributed to the researcher beyond the documented subject classification. A detailed assessment of individual contributions would require review of the researcher’s publications and associated bibliographic records.

  • Research activity within the field of pharmacology.
  • Contribution to the indexed biomedical literature through a reported record of 86 documents.
  • Documented citation activity of 2,110 citations within the supplied profile.
  • A reported h-index of 25 as a measure of citation distribution within the indexed record.

These indicators describe scholarly output and visibility but do not by themselves establish the novelty, methodological quality, clinical relevance, or translational significance of individual studies.

Publications

The supplied research profile reports 86 documents and 2,110 citations. It does not provide a complete publication list, individual publication titles, journal information, publication dates, authorship details, or DOI identifiers for the researcher’s works. Consequently, no specific publication metadata are inferred in this article. For authoritative publication-level information, the researcher’s Scopus author record should be consulted directly. Database coverage, author disambiguation, citation counts, and document totals may change as indexing systems are updated.

Research Impact

The supplied profile reports 2,110 citations across 86 documents and an h-index of 25. These figures indicate that the indexed research record has received substantial citation activity within the reported database profile. Citation counts can provide evidence of scholarly visibility, although they do not by themselves measure research quality, reproducibility, clinical importance, or societal impact.

In pharmacology, research impact may arise through advances in understanding drug mechanisms, identification of biological targets, evaluation of therapeutic efficacy, characterization of safety profiles, or contributions to translational and clinical research. [1][2][3] The significance of a particular contribution therefore depends on the scientific question addressed, methodological rigor, reproducibility, and subsequent use of the findings.

For this profile, the available evidence supports a quantitative description of research impact based on document and citation counts and the reported h-index. Determining broader scientific or clinical impact would require additional evidence, such as highly cited publications, clinical translation, patents, guidelines, collaborations, or documented changes in research or healthcare practice.

Award Suitability

The Best Researcher Award profile is thematically aligned with Mohammad SEYEDABADI’s documented research specialization in pharmacology and the supplied record of scholarly output. The profile reports 86 documents, 2,110 citations, and an h-index of 25, providing several quantitative indicators that may be relevant when evaluating research activity and scholarly visibility.

The researcher is affiliated with Mazandaran University of Medical Sciences and is identified through Scopus Author ID 24460920400 and ORCID 0000-0003-0044-8270. These persistent identifiers provide mechanisms for distinguishing the researcher’s scholarly record and supporting bibliographic verification. On the basis of the supplied information, the profile provides a clear research-area match and a documented scholarly record that can support consideration for an award recognizing research activity. A formal award decision should additionally consider the official eligibility requirements, originality of research, methodological quality, peer-reviewed contributions, field-specific significance, and any qualitative criteria established by the World Science Awards.

Conclusion

Mohammad SEYEDABADI is identified in the supplied academic profile as a pharmacology researcher affiliated with Mazandaran University of Medical Sciences in Iran. The reported research record includes 86 documents, 2,110 citations, and an h-index of 25. These indicators provide a quantitative representation of the researcher’s indexed scholarly activity and citation visibility.

Pharmacology is an established biomedical field with direct relevance to drug mechanisms, therapeutic development, safety assessment, and clinical science. [1][2] The documented research specialization and bibliometric record provide a reasonable academic basis for an award profile focused on research achievement, while a comprehensive assessment of scientific distinction should incorporate publication-level evidence and qualitative evaluation in accordance with the applicable award criteria.

References

  1. Katzung, B. G., Vanderah, T. W. Basic & Clinical Pharmacology. McGraw Hill. This reference provides a general foundation for pharmacodynamics, pharmacokinetics, drug mechanisms, and therapeutic pharmacology.
  2. Brunton, L. L., Hilal-Dandan, R., Knollmann, B. C., eds. Goodman & Gilman’s The Pharmacological Basis of Therapeutics. McGraw Hill. The text provides established principles concerning drug actions, therapeutic effects, mechanisms, and adverse reactions.
  3. Rang, H. P., Dale, M. M., Ritter, J. M., Flower, R. J., Henderson, G. Rang & Dale’s Pharmacology. Elsevier. This reference covers pharmacological mechanisms and the relationship between drugs and biological systems.
  4. Scopus. Scopus Author Profile: Mohammad SEYEDABADI, Author ID 24460920400. The supplied profile identifies the researcher and reports the bibliometric information used in this article.
  5. ORCID. ORCID Record: Mohammad SEYEDABADI, ORCID 0000-0003-0044-8270. The persistent identifier is supplied as the researcher’s ORCID record.

The DOI references above are provided where applicable to support established scholarly literature. The researcher-specific bibliometric values in this article are based on the supplied profile information and should be checked against the current database records for the latest values.

Khadga Raj Aran | Pharmacology | Young Scientist Award

Published on by World Science Awards

Khadga Raj Aran | Pharmacology | Young Scientist Award 

Research Scientist at ISF College of Pharmacy, Moga, India.

Dr. Khadga Raj Aran is a distinguished researcher in neuropharmacology, currently serving as an Associate Professor at ISF College of Pharmacy, Punjab, India. With a deep commitment to understanding the intricacies of neurological diseases, his work is largely focused on exploring neuroprotective therapies and pharmacological interventions. Dr. Aran has garnered several awards and international grants, reflecting his expertise and influence in his field. His contributions extend beyond academia to practical research applications, particularly in experimental pharmacology. Known for his dedication and innovative approach, Dr. Aran’s work has been presented at numerous global conferences, earning him significant recognition. His commitment to pharmacology research is demonstrated by his extensive hands-on skills in animal handling, sophisticated data analysis, and a keen interest in advancing neuropharmacological studies, especially those addressing neurodegenerative diseases. Dr. Aran’s career reflects both an impressive academic journey and a noteworthy dedication to impactful scientific discovery.

Profile

Scopus

Education

Dr. Khadga Raj Aran’s academic journey is marked by a strong foundation in pharmacology and neuropharmacology. He completed his Ph.D. in Pharmacology at the ISF College of Pharmacy, where he achieved a distinction with a high CPI score of 8.93. His research focused on neuroprotective agents against drug-induced neurological damage, which has become the foundation of his career. Prior to this, he earned his M.Pharm in Pharmacology, also with distinction, from the same institution. He holds a B.Pharm degree from East West College of Pharmacy under Rajiv Gandhi University of Health Sciences, Karnataka, where he graduated with honors. This comprehensive academic background has equipped Dr. Aran with a deep knowledge base and the technical skills necessary to excel in his research, making him a well-rounded expert in pharmacology with a keen specialization in neuropharmacology.

Professional Experience

Dr. Aran has accumulated a wealth of experience in pharmacology research and education. He currently holds the position of Associate Professor in the Department of Pharmacology at ISF College of Pharmacy. Previously, he worked as a Senior Research Fellow (SRF) funded by the Indian Council of Medical Research, where he honed his skills in handling complex neuropharmacological research. His early career included a Junior Research Fellowship at Sanjay Gandhi Postgraduate Institute of Medical Sciences. Dr. Aran’s research experience is diverse, encompassing animal handling, various laboratory techniques, and software proficiency for data analysis. His academic role allows him to mentor young scientists, while his research focuses on experimental neurology and pharmacology. Dr. Aran’s dedication and expertise have enabled him to contribute significantly to scientific understanding in these areas, presenting him as a thought leader in his field.

Research Interests

Dr. Aran’s research interests lie at the intersection of pharmacology and neuroscience, with a particular focus on neuroprotection and neurodegenerative diseases. His work explores therapeutic strategies for mitigating the harmful effects of pharmaceutical compounds on the brain, specifically targeting diseases like Parkinson’s and Alzheimer’s. Driven by a desire to contribute solutions to these critical health challenges, Dr. Aran investigates neuropharmacological agents and molecular pathways that could pave the way for new treatments. His research often utilizes advanced animal models and bioassays to study neurological responses, aiming to develop safer, more effective therapeutic options. This focus on neuroprotective pharmacology is fueled by a commitment to advancing public health and deepening scientific understanding of brain function and resilience.

Research Skills

Dr. Aran brings a comprehensive skill set to his neuropharmacology research. He has extensive experience in animal handling techniques across various species, such as rats, mice, and guinea pigs, which he employs for in-depth neurological studies. His proficiency extends to sophisticated laboratory techniques, including ELISA, HPLC-ECD, and stereotaxic surgeries, as well as blood collection and drug administration methods. Dr. Aran is skilled in using software such as GraphPad Prism, EndNote, and ChemDraw for data analysis and documentation, and he utilizes Photoshop and CorelDraw for diagrammatic representations. His research toolkit is completed by a solid command of statistical software like SPSS, enabling him to conduct rigorous data analysis and produce reliable results. These advanced research skills highlight his capability to conduct complex pharmacological studies with precision and accuracy.

Awards and Honors

Throughout his career, Dr. Khadga Raj Aran has received numerous accolades for his scientific contributions and research excellence. Among his prestigious achievements is a best design patent awarded by the Government of India, reflecting his innovative approach to pharmacological research. Dr. Aran has also been recognized internationally, receiving the Best Scholar Award from the International Scientist Awards for his contributions to Engineering, Science, and Medicine. His exceptional review work for the International Journal of Biochemistry Research and Review earned him a Certificate of Excellence in Reviewing. He has further demonstrated his scholarly impact through multiple travel grants for presenting research abroad, including grants from the IBRO and MDS International Congress. Each of these honors underscores Dr. Aran’s dedication to advancing pharmacology, establishing him as a leading figure in neuropharmacology research.

Conclusion:

Dr. Khadga Raj Aran is a strong candidate for the Research for Young Scientist Award due to his solid educational background, research experience, and contributions to neuropharmacology. His achievements, including travel grants, conference awards, and active involvement in national and international research organizations, underscore his potential to make significant contributions to the field. With continued research and collaboration efforts, Dr. Aran has the potential to achieve greater recognition and impact within the scientific community, making him a deserving recipient of the award.

Publications Top Notes

“Emerging roles of cannabinoid receptor CB2 receptor in the central nervous system: therapeutic target for CNS disorders”
Authors: Bala, K., Porel, P., Aran, K.R.
Year: 2024
Journal: Psychopharmacology, Volume 241, Issue 10, Pages 1939–1954
Citations: 0

“Lansoprazole induces hippocampal cell apoptosis and impairs learning and memory functions via activation of tau phosphorylation and Aβ (1–42) pathway in adult rats”
Authors: Aran, K.R., Gupta, G.D., Singh, S.
Year: 2024
Journal: Toxicology and Environmental Health Sciences
Citations: 0

“Mitochondrial dysfunction and oxidative stress in Alzheimer’s disease–A step towards mitochondria based therapeutic strategies”
Authors: Aran, K.R., Singh, S.
Year: 2023
Journal: Aging and Health Research, Volume 3, Issue 4, Article 100169
Citations: 2

“Cryptotanshinone ameliorates cladribine-induced cognitive impairment in rats”
Authors: Aran, K., Gupta, G., Singh, S.
Year: 2023
Journal: Asian Pacific Journal of Tropical Biomedicine, Volume 13, Issue 7, Pages 296–305
Citations: 0

“Amelioration of Cognitive Deficit by Cryptotanshinone in a Long-term Utilisation of Proton Pump Inhibitor-Induced Alzheimer’s Disease-Like Condition in a Rat Model”
Authors: Aran, K.R., Das Gupta, G., Singh, S.
Year: 2023
Journal: Revista Brasileira de Farmacognosia, Volume 33, Issue 3, Pages 595–609
Citations: 2